169 related articles for article (PubMed ID: 31670961)
1. Nucleolar Stress Induction by Oxaliplatin and Derivatives.
Sutton EC; McDevitt CE; Prochnau JY; Yglesias MV; Mroz AM; Yang MC; Cunningham RM; Hendon CH; DeRose VJ
J Am Chem Soc; 2019 Nov; 141(46):18411-18415. PubMed ID: 31670961
[TBL] [Abstract][Full Text] [Related]
2. Influence of Ring Modifications on Nucleolar Stress Caused by Oxaliplatin-Like Compounds.
McDevitt CE; Guerrero AS; Smith HM; DeRose VJ
Chembiochem; 2022 Jul; 23(14):e202200130. PubMed ID: 35475312
[TBL] [Abstract][Full Text] [Related]
3. Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?
McDevitt CE; Yglesias MV; Mroz AM; Sutton EC; Yang MC; Hendon CH; DeRose VJ
J Biol Inorg Chem; 2019 Sep; 24(6):899-908. PubMed ID: 31494760
[TBL] [Abstract][Full Text] [Related]
4. Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin.
Sutton EC; DeRose VJ
J Biol Chem; 2021; 296():100633. PubMed ID: 33819479
[TBL] [Abstract][Full Text] [Related]
5. Time-Dependent Studies of Oxaliplatin and Other Nucleolar Stress-Inducing Pt(II) Derivatives.
Pigg HC; Yglesias MV; Sutton EC; McDevitt CE; Shaw M; DeRose VJ
ACS Chem Biol; 2022 Aug; 17(8):2262-2271. PubMed ID: 35917257
[TBL] [Abstract][Full Text] [Related]
6. Comparison of click-capable oxaliplatin and cisplatin derivatives to better understand Pt(ii)-induced nucleolar stress.
Guerrero AS; O'Dowd PD; Pigg HC; Alley KR; Griffith DM; DeRose VJ
RSC Chem Biol; 2023 Oct; 4(10):785-793. PubMed ID: 37799581
[TBL] [Abstract][Full Text] [Related]
7. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
8. Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.
O'Dowd PD; Guerrero AS; Alley KR; Pigg HC; O'Neill F; Meiller J; Hobbs C; Rodrigues DA; Twamley B; O'Sullivan F; DeRose VJ; Griffith DM
ACS Chem Biol; 2024 Apr; 19(4):875-885. PubMed ID: 38483263
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-induced damage of cellular DNA.
Woynarowski JM; Faivre S; Herzig MC; Arnett B; Chapman WG; Trevino AV; Raymond E; Chaney SG; Vaisman A; Varchenko M; Juniewicz PE
Mol Pharmacol; 2000 Nov; 58(5):920-7. PubMed ID: 11040038
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nucleolar transcription by oxaliplatin involves ATM/ATR kinase signaling.
Nechay M; Wang D; Kleiner RE
Cell Chem Biol; 2023 Aug; 30(8):906-919.e4. PubMed ID: 37433295
[TBL] [Abstract][Full Text] [Related]
11. Specificity of platinum-DNA adduct repair.
Chaney SG; Vaisman A
J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
[TBL] [Abstract][Full Text] [Related]
12. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
13. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
Saris CP; van de Vaart PJ; Rietbroek RC; Blommaert FA
Carcinogenesis; 1996 Dec; 17(12):2763-9. PubMed ID: 9006117
[TBL] [Abstract][Full Text] [Related]
14. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the reactivity of oxaliplatin, pt(diaminocyclohexane)Cl2 and pt(diaminocyclohexane1)(OH2)2(2+) with guanosine and L-methionine.
Verstraete S; Heudi O; Cailleux A; Allain P
J Inorg Biochem; 2001 Mar; 84(1-2):129-35. PubMed ID: 11330471
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells.
Luo FR; Wyrick SD; Chaney SG
Oncol Res; 1998; 10(11-12):595-603. PubMed ID: 10367941
[TBL] [Abstract][Full Text] [Related]
18. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review).
Chaney S
Int J Oncol; 1995 Jun; 6(6):1291-305. PubMed ID: 21556672
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond E; Faivre S; Woynarowski JM; Chaney SG
Semin Oncol; 1998 Apr; 25(2 Suppl 5):4-12. PubMed ID: 9609103
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
